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Parkinson’s disease (PD) is characterized by a general dopamine
deﬁciency (Scatton, Jovoy-Agrid, Rouquier, Dubois, & Agid, 1993).
Although motor impairment has been the focus of the clinical eval-
uation and therapy of PD patients, non-motor manifestations such
as cognitive impairment have also been studied (Lang & Lozano,
1998) and evidence for abnormalities of early vision in Parkinson’s
disease is widely reported in the literature (Armstrong, 2008;
Bodis-Wollner, 1990; Bulens, Meerwaldt, Dan der Wildt, &
Keemink, 1986; Crevits, 2003; Djamgoz, Hankins, Hirano, & Archer,
1997; Harnois & Di Paolo, 1990; Harris, 1998; Masson, Mestre, &
Blin, 1993; McMahon, Knapp, & Dowling, 1989; Riklan, 1972;
Rodnitzky, 1998; Wink & Harris, 2000). It is suggested that the ob-
served changes in perception as well as other non-motor manifes-
tations of Parkinson’s disease are due to varied patterns of
degeneration in dopaminergic neural systems. Some anatomical
studies show that dopamine in Parkinsonian retina is reduced
and dopaminergic neurons appear distorted (Bodis-Wollner,
1990; Djamgoz et al., 1997; Harnois & Di Paolo, 1990; Harris,
1998; Masson et al., 1993; Rodnitzky, 1998; Wink & Harris, 2000).
Other researches have demonstrated a substantial reduction in
retinal dopamine content in MPTP-treated monkeys (Ghilardi,
Bodis-Wollner, Onofrj, Marx, & Glover, 1988). Dopamine amacrinell rights reserved.
e Sciences (SCS), Institute for
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jevand).cells are found in the retina of many species including human
(Frederick, Rayborn, Laties, Lam, & Hollyﬁeld, 1982) and the Inter-
plexiform cells in humans and other primates which are in contact
with the amacrine and horizontal cells employ dopamine as a neu-
rotransmitter (Dowling, 1991). Prolonged visual evoked potential
latencies and abnormal electroretinographic patterns, both of
which respond to levodopa therapy, have been demonstrated in
Parkinson’s disease patients and in primates with experimental
Parkinsonism (Rodnitzky, 1998). It is reasonable therefore to as-
sume that disruption of dopamine cells in the retina plays a major
role in changes of basic visual perception in PD patients.
Among well known studies of perceptual changes in PD patients
are reduction in theability todetectﬂicker (Riklan, 1972), abnormal-
ities in spatial contrast sensitivity function (Bulens et al., 1986), de-
creased dynamic contrast sensitivity (Masson et al., 1993), changes
in the receptive ﬁeld size of the horizontal cells (McMahon et al.,
1989) and visual abnormalities which are similar to the changes
accompany dark adaptation in normal subjects (the parkinsonian
retina behaves as though inappropriately dark-adapted) (Wink &
Harris, 2000). In general, the involvement of retinal dopamine deﬁ-
ciency in some of the visual deﬁcits in Parkinson’s disease is strong
(Djamgoz et al., 1997). But, although many such abnormalities
including cognitive deﬁcits are reported in the literature, to our
knowledge no such study has yet described change in the duration
of afterimage perception. This is importantwith respect to the ques-
tion of howdopamine deﬁciencymay inﬂuence afterimage duration
in PD patients. According to Hayhoe, Benimoff, and Hood (1987)
there are three distinct processes underlying light adaptation: a fast
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tractive process operating over several seconds (Hayhoe, Levin, &
Kosel, 1992). Among all the other retinal cells involved in early
stages of visual processing it is the Interplexiform (IP) circuit which
operatesvery slowlybyneural standardswith a timeconstanton the
order of several seconds (Wilson, 1997). One consequence of retinal
light adaptation is the production of retinal afterimageswhich occur
when adjacent patches of retina are adapted to different light inten-
sities. In fact, experimental measurements have revealed that nega-
tive afterimage decays exponentially with a time constant of 4–8 s
(Burbeck & Kelly, 1984).
This predicts an afterimage decay time well above 7–8 s.
According to one model (Wilson, 1997), the slow time course of
afterimage decay can be explained by the very slow dynamics of
the IP layer. In other words the slow build-up and decay of retinal
dopaminergic neuromodulation of the IP cells is assumed to be
responsible for the slow decay of the negative afterimage (Wilson,
1999). A disruption of this dopaminergic neuromodulation process
therefore, should produce a corresponding change in the duration
of afterimage perception. Our results show that this is indeed the
case i.e., a reduction in negative afterimage duration is observed
in patients with Parkinson’s disease where a possible reduction
of retinal dopamine is expected.2. Methods
2.1. Subjects
Four patients with Parkinson’s disease participated in the
experiments. Patients were selected from the outpatient clinic of
neurosurgery of Shahid Beheshti University of Medical Sciences.
Patients’ ages varied between 42 and 65.
Inclusion criterion was the ability of the patients to learn the
tasks during the learning phase properly.
A neurologist consultation was obtained, who determined sub-
jects were off drug during the test. All patients were off drug dur-
ing the learning and the test phase.
Four self-declared neurologically healthy participants who had
normal mini mental state examinations served as the control group
for identifying the afterimage duration in the present experimental
set-up.
No subject had acute, confounding medical, psychiatric or neu-
rologic conditions.
All subjects had normal or corrected to normal vision.
The groups were matched for age.
Subject characteristics are listed in Table 1.
2.2. Equipments
The stimulus sequence generation and experimental control
were done by MATLAB Psychophysics Toolbox (Pelli, 1997;Table 1
Subject characteristics are listed.
Gender Age
Patients (n = 4)
1 M 45
2 M 42
3 F 50
4 M 65
Controls (n = 4)
1 F 63
2 M 35
3 M 50
4 M 56Brainard, 1997) running on a 3 GHz Intel PC processor. Images
were displayed on a 1500 ﬂat, CRT, RGB, LG color monitor (1024H
800V pixel resolution at 75 Hz frame rate, c = 1.93).
2.3. Procedures
In the present study we measured the negative afterimage.
The experiment was composed of two parts; the training phase
and the test phase. Subjects were examined individually in a
dark, quiet room while seated in an adjustable chair in front of
a computer. The distance between monitor and subject was
53 cm.
2.3.1. Training phase
To make sure that the subjects were able to report the presence
of a low contrast image accurately (similar to the expected afterim-
age in the main experiment), subjects took part in the training
phase. Subjects who were successful in the training phase took part
in the test phase as well. This way we made sure that performance
differences in the test phase were not caused by any other cogni-
tive disorder in the patients, hindering their sensory-motor
abilities.
During the training phase subjects ﬁxated at a red cross in the
middle of a white screen. A gray circle appeared and disappeared
at random intervals (Fig. 1) Subjects were instructed to push the
key whenever the circle showed up and release it as soon as the
circle disappeared.
2.3.2. Test phase
In the test phase, a common procedure for observing negative
afterimages was adopted as follows:
Initially a white circle on a dark background appeared for about
20 s and was replaced with a white screen with a ﬁxation point at
the middle, after the adaptation period (Fig. 2). Subjects were
asked to press the key whenever they saw the negative afterimage
and to release it when no afterimage was seen.
The trial ended after 60 s and the screen turned black at the end
of each trial. Inter-trail interval was about 5 s and each subject
went through 20 trials.
2.4. Data analysis
To evaluate the difference in afterimage duration between the
two groups (patients/controls) we used unpaired sample T-test
(the signiﬁcant level was deﬁned as P < 0.05 (two-tailed)).
3. Results
To make sure that the subjects were accurately reporting the
appearance of the gray circle during the experiment we calculated
the error on reporting the duration ‘‘error on reporting the dura-
tion” during the training phase by subtracting the onset error from
the offset error.
Subjects with delays or errors on reporting the duration outside
an acceptable range of about one second in training phase were ex-
cluded from the experiment.
We excluded the results of two subjects from our ﬁnal analysis
– these subjects showed astonishing low afterimage duration of
about 1–2 s and showed good performance on their training phase,
therefore they were not excluded during the test phase. The rea-
sons are explained in the discussion.
Four PD patients were chosen for further analysis.
There was no signiﬁcant difference of the ‘‘error on reporting
the duration” of the stimuli in the ﬁrst part between two groups
(patients/controls) (Table 2).
Fig. 1. During this phase subjects ﬁxated at a red cross in the middle of a white screen. A gray circle appeared and disappeared at random intervals, while subjects pressed
and held the key for as long as the image remained on the screen. Subjects were instructed to release the key immediately after the disappearance of the stimulus.
Fig. 2. Initially a white circle on a dark background appeared for about 20 s after which a white screen with a ﬁxation point at the middle was shown. Subjects were to press a
key upon the appearance of the negative afterimage and to release it when no afterimage was seen. Inter-trail interval was about 5 s.
Table 3
The negative afterimage durations were signiﬁcantly shorter in patients with PD as
compared with control subjects, P-value = 4.63E03.
Duration S1 S2 S3 S4 Mean SEM P-value
Patients 4.38 4.63 5.28 5.04 4.83 0.20 4.63E03
Controls 9.14 8.63 10.95 7.89 9.15 0.65
S: mean afterimage duration of subjects (either patients or controls), SEM: standard
error mean.
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patients with PD as compared with control subjects (P-
value = 4.63E03) (Table 3). The same results were obtained after
correcting for the error on reporting the duration (P-
value = 4.40E03).
The afterimage duration in the control group was longer than
6 s in 91% of trials (the oldest subject (C1) showed the longest
afterimage duration). While for patients it was shorter than 6 s in
83% of the trials. In other words in most trials, PD patients reportedTable 2
In the training phase the error on reporting the duration was calculated by subtracting
the onset from the offset error. There was no signiﬁcant difference of the ‘‘error on
reporting the duration” of the stimuli in the ﬁrst part between two groups (patients/
controls).
Subjects Error on reporting
the onset of stimuli
(s)
Error on reporting
the offset of stimuli
(s)
Error on reporting
the duration of
stimuli (s)
P1 0.55 0.69 0.14
P2 0.63 0.24 0.39
P3 0.51 0.39 0.12
P4 1.52 0.58 0.94
Mean 0.80 0.47 0.32
SEM 0.24 0.10 0.23
C1 0.55 0.75 0.20
C2 0.73 0.30 0.43
C3 0.40 0.37 0.03
C4 0.46 0.41 0.05
Mean 0.53 0.46 0.08
SEM 0.07 0.10 0.13
P-value 0.35 0.90 0.39
P: patient, C: control, SEM: standard error mean.afterimage durations shorter than 6 s while in the case of control
subjects almost the opposite held true. Besides, in none of the
off-drug cases where the patients did well on the training phase
was a negative result observed (i.e., longer duration of afterimage
duration).
Fig. 3 shows the result in more details for both the controls and
the four off-drug patients.4. Discussion
The objective of the present study was to investigate the effects
of dopamine deﬁciency in Parkinson patients on afterimage dura-
tion. Based on Wilson’s model of light adaptation, both the forma-
tion and decay of afterimages in the retina can be explained by the
very slow neuromodulatory role of the Interplexiform (IP) layer
cells. Our prediction was that any deﬁciency or reduction of dopa-
mine in IP layer will result in a corresponding reduction in the per-
ception of afterimage duration.
Here in our experiment, results of subjects agreed well with the
perception of afterimage duration (above 7–8 s) in normal popula-
tion reported in literature (Burbeck & Kelly, 1984; Kelly & Marti-
nez-Vriegas, 1993). The results of the present study show a
Fig. 3. This graph shows the result in more details for both the controls and patients. Vertical axis represents number of trails and horizontal axis represents afterimage
duration in second. Each dot represents number of trials subjects reported corresponding afterimage duration. PD curve shows the results for all of the patients as a group.
Control curve shows the same for normal subjects.
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jects compared to the normal control subjects as big as 2–3 s. Gi-
ven that all the other cells including the retinal ganglion cells
have time constants in the order of milliseconds, had it been that
dopamine based processes were operating on a shorter time con-
stant in the millisecond range the result would have been different
and no reduction would be observed.
Our result does not rule out other theories of afterimage per-
ception such as bleaching of the photoreceptors or the involve-
ment of yet higher cortical circuitries. Wilson’s model, however,
argues for a direct link between a perceptual experience, negative
afterimage duration, and a speciﬁc neural substrate, neuromodu-
latory dopaminergic system in the retina. Based on the known ret-
inal anatomy (Dowling, 1987) the model consists of two distinct
neural pathways; a direct pathway from the cones to bipolar to
retinal output ganglion cells and an indirect or adaptive pathway
consisting of the amacrine to Interplexiform to horizontal cells.
For our present purpose this amarcine to Interplexiform to hori-
zontal cell circuitry acts a neuromodulatory role and uses dopa-
mine as its neurotransmitter. The two other major circuitries;
the so-called subtractive feedback circuitry of the horizontal to
cone cells and the divisive feedback circuitry of the amacrine to
the bipolar cells operate on the millisecond range and according
to Wilson’s model could not be the basis for the long duration
of negative afterimage duration. The interplay of the time con-
stants in the adaptive pathway makes it the only candidate for
causing such effects in the range of several seconds. Reduction
of dopamine in the retina of PD patients might result in an in-
crease in the neuromodulatory activity of the IP cells which can
shorten the time constant of the horizontal cells. Overall Wilson’s
model well predicts the negative afterimage formation generated
by a stationary grating. The important point is that the negative
afterimage is a byproduct of retinal neuromodulation by IP cells.
Another important aspect of the model is that in case only the di-
rect pathway is active as when a fast ﬂash of light is shown or as a
result of reduction of dopamine in the IP circuitry the model pre-dicts a slowing down of the corresponding decay and formation of
afterimage duration.
Two of the PD subjects showed astonishing low afterimage dura-
tionof about1–2 sandalso showedgoodperformanceon their train-
ing phase. This compiled well with the main hypothesis of the
present study butwe excluded the results of these subjects in the ﬁ-
nal analysis for two reasons: either theafterimage formationprocess
wasdifferentor the subjectswerealmostdepletedof dopamine. This
of coursewould be a subject for further researchwhere a larger scale
study of low to high graded Parkinson patients is possible.
In one other patient where the patient was tested in both on-
drug and off drug conditions the result showed a longer duration
of afterimage when the usual medical treatment of levodopa had
been taken around 1–2 h before the experiments. However, as it
is recently reported that dopaminergic medication may improve
certain types of perceptual performance and hinder others (Ashley
et al., 2007), in this case elongation of afterimage might be caused
by a different perceptual mechanism. Therefore, although the long-
er duration of perceived afterimage in the on-drug condition is in
accordance with our prediction we did not pool the results of this
subject as yet no rising of dopamine level in the retina is reported
following L-Dopa therapy.
A systematic differentiation of the on/off-drug cases of patients
with PD must await a thorough investigation in a future research.
What is important, however, is that in none of the off-drug cases
where the patients did well on the training phase did we observe
a negative result (i.e., longer duration of afterimage duration).5. Conclusion
Our results show a signiﬁcant reduction of negative afterimage
duration in off-drug patients with Parkinson’s disease. As we ar-
gued in the discussion section this result correlates well with a
possible deﬁciency in the retinal dopaminergic system of the PD
patients.
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duration can be thought of as an indirect measure of dopamine
depletion level in the retina and carries on some rather interesting
predictions about the state of the PD in the general population.
It remains to be shown, for example, whether a larger scale
study on patients with mild to moderate Parkinson’s disease will
replicate similar ﬁndings and whether afterimage duration co-var-
ies with severity of the disease.
This result also have implications for the existing diagnostic
measures in clinical practice in that a reduction in afterimage dura-
tion can signify the progressive rate of the dopaminergic disruption
in patients with Parkinson’s disease.
This motivates further research on population of PD patients
with mild to moderate category as well as research on (on/off-
drug) cases to be carried out in the near future.
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